GE Healthcare Agrees to Acquire Certain Assets of Rayence, a Subsidiary of Vatech, Acknowledging Korea’s Technology in

  GE Healthcare Agrees to Acquire Certain Assets of Rayence, a Subsidiary of
  Vatech, Acknowledging Korea’s Technology in Mammography

  *GE Healthcare to provide a quality solution with affordable costs while
    broadening mammography portfolio by acquiring Value Digital Mammography
  *The acquisition represents GE Korea’s growth strategy, “In Korea, For the
    World”
  *Win-win partnership will create a platform for Rayence to enter overseas
    markets achieved through the supply contract of CMOS detector

Business Wire

SEOUL, Korea -- June 21, 2013

GE Healthcare (NYSE: GE) today announced that it has agreed to acquire certain
Mammography assets of Rayence, a subsidiary of Vatech Co Ltd (KOSDAQ: 043150),
a Korean X-Ray manufacturer. TheMammography assets of Rayence will, at
closing, become part of theDetection & Guidance Solutions (DGS)business unit
of GE Healthcare.

Given the dynamic emerging healthcare market, this acquisition
isstrategicallysignificant as it will allow GE Healthcare to expandits
mammography product range to the ValueMammographysegment, estimated to be
over $200M. "This opportunity represents another very important step in the
company’s strategy of offering complete solutions that meet the needs of our
global customers, while helping to provide more access to quality healthcare
at a lower cost," said Hooman Hakami, President & CEO—Detection & Guidance
Solutions.

“At GE Healthcare we are very excited about the future of Women’s Healthcare.
With the mammography assets of Rayence, tailored for regions with specific
cost and access needs, we add capability that allows us to bring affordable
mammography solutions to new users and rural communities around the world, in
particular physicians undertaking screening programs for breast cancer
diagnosis. In addition, when combined with GE's core imaging capabilities, we
will create a system that will havebest in class image quality atthe lowest
total cost of ownership,” said Prahlad Singh, General Manager – Women’s
Health, GE Healthcare, Detection & Guidance Solutions (DGS).”

In addition, the acquisition is part of GE Korea’s growth strategy, “In Korea,
For the World”. This deal is especially meaningful as GE Healthcare has
identified a Korean company with remarkable technologies in mammography and
plans to continue local engineering and production while targeting the global
market. GE Healthcare will also play a crucial role for Rayence to secure a
sales channel in the global market by signing a separate supply agreement of
CMOS detector.

Laurent Rotival, President and CEO of GE Healthcare Korea, said, “This
acquisition is another example of Korea’s world class R&D capabilities coming
together with GE’s global technology leadership. Our ‘In Korea, For the World’
strategy creates win-win partnerships with local talent and companies.”

James Hyun, CEO of Rayence said, “This deal is meaningful in that Rayence has
secured a solid global business partner for supplying CMOS detectors. I am
very pleased that Rayence’s technology capabilities were acknowledged and
products made by Rayence will be distributed to the world by GE Healthcare,
thereby contributing to the enhancement of women’s health. Rayence plans to
invest the money earned through the sale of our mammography assets into the
R&D of core parts for x-ray devices including detectors and expansion of
manufacturing lines.”

Rotival added, “GE Healthcare will continue to be a strong partner by
investing in Korea and strengthening our joint commitment to our customers and
our communities in helping them deliver the best quality and cost effective
patient care.”

The transaction is subject to customary closing conditions and is expected to
close in the third quarter.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services to
meet the demand for increased access, enhanced quality and more affordable
healthcare around the world. GE (NYSE: GE) works on things that matter - great
people and technologies taking on tough challenges. From medical imaging,
software & IT, patient monitoring and diagnostics to drug discovery,
biopharmaceutical manufacturing technologies and performance improvement
solutions, GE Healthcare helps medical professionals deliver great healthcare
to their patients.

About Rayence Co., Ltd.

Rayence is a global digital X-ray imaging components & solutions provider. It
has a very competitive full line-up of Flat Panel Detectors (FPD) based on
a-SI TFT and CMOS technologies, and generators. Rayence is capable of
providing customized imaging solutions for medical, dental, veterinary, and
industrial X-ray applications. www.rayence.com

Contact:

Media Inquiries
GE Healthcare Korea
MyongOk Yoon, 02-6201-3302/010-7370-2191
Younghwa Han, 02-6201-3318/010-9080-8157
Pilar Anton Serrano, pilar.antonserrano@ge.com
or
Rayence
HyungJung Koh, 031-8015-6036/010-2715-8405
Yoosun Cho, 031-8015-6040/010-9359-9886
or
News Communications
Eunjung Choi, 02-6323-5040/ 010-5602-0922
Yoojung Ha, 02-6323-5060/ 010-7162-9150
Doyoon Park, 02-6323-5074/ 010-3766-0452